Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1996 - 1997
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1993 - 1996
Case Western Reserve University School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2003 - Present
OH State Medical License 1999 - 2026
IL State Medical License 2002 - 2020
NY State Medical License 2003 - 2020
MI State Medical License 2002 - 2018
PA State Medical License 1996 - 2006- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Start of enrollment: 2003 Oct 01
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Start of enrollment: 2003 Nov 01
- Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers Start of enrollment: 2008 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsFertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.Hatem A Azim Jr, Samuel M Niman, Ann H Partridge, Isabelle Demeestere, Monica Ruggeri
Journal of Clinical Oncology. 2024-08-10 - 1 citationsPhase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, Carley Mitchell, Paul G Pavicic Jr
Clinical Cancer Research. 2024-01-05 - 18 citationsPregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.Matteo Lambertini, Eva Blondeaux, Elisa Agostinetto, Anne-Sophie Hamy, Hee Jeong Kim
JAMA. 2024-01-02
Authored Content
- Pondering the RxPONDER StudyDecember 2020
Press Mentions
Merck-AstraZeneca Breast Cancer Drug Reduces Risk of Death by 28% in Patients Diagnosed Early, Clinical Trial ShowsDecember 21st, 2024- The Treatment Cancer Survivors Are MissingApril 17th, 2023
- New Hormonal Treatment Orserdu Approved for Metastatic Breast CancerFebruary 13th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
